STOCK TITAN

Amalgamated Bank. Financials

AMAL
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Amalgamated Bank. (AMAL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMAL FY2025

Amalgamated’s balance-sheet expansion is still producing cash, but each new dollar of equity is earning a lower return.

From FY2023 through FY2025, operating cash flow exceeded net income each year, so reported earnings were translating into cash rather than being created by accounting timing. But ROE still eased from 15.0% to 13.2%, which implies the company is expanding on a larger capital base that is becoming slightly less productive for shareholders.

Capex was only $1.4M against $135.8M of operating cash flow in FY2025. That is the signature of a capital-light operating model inside a very large balance sheet: cash generation depends far more on asset/liability management than on replacing equipment or building facilities.

Cash and equivalents jumped to $291.2M in FY2025 from $60.7M a year earlier. With financing cash flow at $472.7M and free cash flow at $134.4M, the larger cash buffer appears to have been built more by funding flows than by operations alone, a reminder that liquidity can change quickly even when earnings are steady.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency Credit Quality Stability 45 / 100
Financial Health Score 45/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Amalgamated Bank.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
72
Growth
43
Capital
16
Efficiency
88
Stability
49
Piotroski F-Score Partial
4/6

Amalgamated Bank. passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.30x

For every $1 of reported earnings, Amalgamated Bank. generates $1.30 in operating cash flow ($135.8M OCF vs $104.5M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$422.2M
YoY+5.2%
5Y CAGR+17.3%

Amalgamated Bank. generated $422.2M in revenue in fiscal year 2025. This represents an increase of 5.2% from the prior year.

EBITDA
N/A
Net Income
$104.5M
YoY-1.9%
5Y CAGR+17.7%

Amalgamated Bank. reported $104.5M in net income in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

EPS (Diluted)
$3.41
YoY-0.9%
5Y CAGR+18.2%

Amalgamated Bank. earned $3.41 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 0.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$134.4M
YoY+9.9%
5Y CAGR+15.9%

Amalgamated Bank. generated $134.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 9.9% from the prior year.

Cash & Debt
$291.2M
YoY+379.4%
5Y CAGR+49.7%

Amalgamated Bank. held $291.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
30M
YoY-2.8%
5Y CAGR-0.8%

Amalgamated Bank. had 30M shares outstanding in fiscal year 2025. This represents a decrease of 2.8% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
24.7%
YoY-1.8pp
5Y CAGR+0.5pp

Amalgamated Bank.'s net profit margin was 24.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.8 percentage points from the prior year.

Return on Equity
13.2%
YoY-1.9pp
5Y CAGR+4.5pp

Amalgamated Bank.'s ROE was 13.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.9 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$32.3M
YoY+2762.5%
5Y CAGR+35.8%

Amalgamated Bank. spent $32.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 2762.5% from the prior year.

Capital Expenditures
$1.4M
YoY-22.3%
5Y CAGR-3.1%

Amalgamated Bank. invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 22.3% from the prior year.

AMAL Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $109.3M+1.4% $107.9M-1.6% $109.6M+5.3% $104.1M+3.4% $100.7M-1.8% $102.6M-0.2% $102.8M+3.9% $99.0M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $25.8M-3.0% $26.5M+4.3% $25.5M+9.5% $23.2M-0.3% $23.3M-5.6% $24.7M+3.9% $23.8M+3.1% $23.0M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $29.2M-2.8% $30.0M-9.5% $33.1M+6.2% $31.2M+3.6% $30.1M+2.1% $29.5M-4.0% $30.7M+3.2% $29.8M
Income Tax $8.8M+33.4% $6.6M-33.1% $9.9M+4.5% $9.5M-2.5% $9.7M+13.4% $8.6M-16.8% $10.3M+14.0% $9.0M
Net Income $25.2M-5.3% $26.6M-0.5% $26.8M+3.1% $26.0M+3.8% $25.0M+2.2% $24.5M-12.4% $27.9M+4.4% $26.8M
EPS (Diluted) $0.84 N/A $0.88+4.8% $0.84+3.7% $0.81 N/A $0.90+3.4% $0.87

AMAL Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $9.2B+3.4% $8.9B+2.2% $8.7B+0.7% $8.6B+4.1% $8.3B+0.3% $8.3B-1.9% $8.4B+2.0% $8.3B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $179.7M-38.3% $291.2M+152.0% $115.5M-32.5% $171.1M+160.3% $65.7M+8.2% $60.7M-59.3% $149.2M+157.3% $58.0M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $12.9M0.0% $12.9M0.0% $12.9M0.0% $12.9M0.0% $12.9M0.0% $12.9M0.0% $12.9M0.0% $12.9M
Total Liabilities $8.4B+3.6% $8.1B+2.1% $7.9B+0.5% $7.9B+4.2% $7.5B0.0% $7.5B-2.2% $7.7B+1.5% $7.6B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $807.6M+1.7% $794.5M+2.4% $775.6M+2.9% $754.0M+2.4% $736.0M+4.0% $707.7M+1.4% $698.2M+8.1% $646.0M
Retained Earnings $587.3M+3.5% $567.3M+4.1% $544.9M+4.3% $522.4M+4.3% $500.8M+4.3% $480.1M+4.5% $459.4M+5.6% $435.2M

AMAL Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $56.8M+52.9% $37.1M-6.0% $39.5M+58.5% $24.9M-27.1% $34.2M+18.0% $29.0M-18.9% $35.8M+27.7% $28.0M
Capital Expenditures $6.1M+811.0% -$855K-171.7% $1.2M+267.6% -$712K-140.6% $1.8M+137.5% $738K+26.2% $585K+138.8% $245K
Free Cash Flow $50.7M+39.7% $36.3M-5.3% $38.3M+58.2% $24.2M-25.4% $32.5M+14.8% $28.3M-19.7% $35.2M+26.7% $27.8M
Investing Cash Flow -$387.4M-1659.2% -$22.0M+81.2% -$117.0M+49.6% -$232.4M-3415.0% -$6.6M-112.0% $55.3M+170.9% -$78.0M+61.4% -$202.0M
Financing Cash Flow $219.1M+36.5% $160.5M+630.0% $22.0M-93.0% $312.8M+1481.8% -$22.6M+86.9% -$172.8M-229.4% $133.5M+73.9% $76.7M
Dividends Paid $5.3M+25.8% $4.2M-1.3% $4.2M-5.2% $4.5M+4.5% $4.3M+16.4% $3.7M-0.3% $3.7M-1.2% $3.7M
Share Buybacks $2.8M-68.1% $8.7M-16.6% $10.4M+7.9% $9.7M+175.7% $3.5M+315.4% $845K $0 $0

AMAL Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 23.1%-1.6pp 24.7%+0.3pp 24.4%-0.5pp 25.0%+0.1pp 24.9%+1.0pp 23.9%-3.3pp 27.2%+0.2pp 27.0%
Return on Equity 3.1%-0.2pp 3.4%-0.1pp 3.5%0.0pp 3.5%+0.1pp 3.4%-0.1pp 3.5%-0.5pp 4.0%-0.1pp 4.1%
Return on Assets 0.3%-0.0pp 0.3%0.0pp 0.3%0.0pp 0.3%0.0pp 0.3%0.0pp 0.3%-0.0pp 0.3%0.0pp 0.3%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 10.36+0.2 10.16-0.0 10.20-0.2 10.43+0.2 10.26-0.4 10.67-0.4 11.05-0.7 11.77
FCF Margin 46.4%+12.7pp 33.7%-1.3pp 35.0%+11.7pp 23.3%-9.0pp 32.2%+4.7pp 27.6%-6.7pp 34.2%+6.2pp 28.1%

Similar Companies

Frequently Asked Questions

Amalgamated Bank. (AMAL) reported $422.2M in total revenue for fiscal year 2025. This represents a 5.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Amalgamated Bank. (AMAL) revenue grew by 5.2% year-over-year, from $401.3M to $422.2M in fiscal year 2025.

Yes, Amalgamated Bank. (AMAL) reported a net income of $104.5M in fiscal year 2025, with a net profit margin of 24.7%.

Amalgamated Bank. (AMAL) reported diluted earnings per share of $3.41 for fiscal year 2025. This represents a -0.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amalgamated Bank. (AMAL) had a net profit margin of 24.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Amalgamated Bank. (AMAL) has a return on equity of 13.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Amalgamated Bank. (AMAL) generated $134.4M in free cash flow during fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Amalgamated Bank. (AMAL) generated $135.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Amalgamated Bank. (AMAL) had $8.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Amalgamated Bank. (AMAL) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Amalgamated Bank. (AMAL) spent $32.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Amalgamated Bank. (AMAL) had 30M shares outstanding as of fiscal year 2025.

Amalgamated Bank. (AMAL) had a debt-to-equity ratio of 10.16 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Amalgamated Bank. (AMAL) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Amalgamated Bank. (AMAL) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Amalgamated Bank. (AMAL) has an earnings quality ratio of 1.30x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Amalgamated Bank. (AMAL) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top